Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1986 Sep 27;293(6550):786–789. doi: 10.1136/bmj.293.6550.786

Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.

S Ikram, S Lewis, C Bucknall, I Sram, N Thomas, R Vincent, D Chamberlain
PMCID: PMC1341572  PMID: 3094657

Abstract

A controlled trial in 149 patients admitted to a district hospital with probable myocardial infarction tested the effect of 30 units of anisoylated plasminogen streptokinase activator complex (APSAC) on indices of infarct size. Patients were grouped prospectively according to whether they entered the trial within two and a half hours (early entry) or between two and a half and four hours (late entry) after onset of the symptoms. Sixty seven of 73 patients in the control group showed increased plasma activity of myocardial creatine kinase isoenzyme that was diagnostic of infarction compared with only 60 of 76 who received APSAC. The difference was significant overall but occurred predominantly in the early entry group. The patients who received APSAC had more early ventricular arrhythmias, compatible with reperfusion, and showed greater preservation of R waves during admission to hospital. Unwanted effects were generally minor and more common in the actively managed group than the control group (26% v 3%). After nine to 12 months of follow up 12 patients in the control group had died compared with seven in the actively managed group. The ease of administration and the apparent efficacy of APSAC suggest that it is suitable for use in a district hospital for patients with suspected acute myocardial infarction.

Full text

PDF
786

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aber C. P., Bass N. M., Berry C. L., Carson P. H., Dobbs R. J., Fox K. M., Hamblin J. J., Haydu S. P., Howitt G., MacIver J. E. Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. Br Med J. 1976 Nov 6;2(6044):1100–1104. doi: 10.1136/bmj.2.6044.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Been M., de Bono D. P., Muir A. L., Boulton F. E., Hillis W. S., Hornung R. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Br Heart J. 1985 Mar;53(3):253–259. doi: 10.1136/hrt.53.3.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bett J. H., Castaldi P. A., Hale G. S., Isbister J. P., McLean K. H., O'Sullivan E. F., Biggs J. C., Chesterman C. N., Hirsh J., McDonald I. G. Australian multicentre trial of streptokinase in acute myocardial infarction. Lancet. 1973 Jan 13;1(7794):57–60. doi: 10.1016/s0140-6736(73)90463-7. [DOI] [PubMed] [Google Scholar]
  4. Davies G. J., Chierchia S., Maseri A. Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. Some clinical observations. N Engl J Med. 1984 Dec 6;311(23):1488–1492. doi: 10.1056/NEJM198412063112306. [DOI] [PubMed] [Google Scholar]
  5. Davies M. J., Thomas A. C. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J. 1985 Apr;53(4):363–373. doi: 10.1136/hrt.53.4.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DeWood M. A., Spores J., Notske R., Mouser L. T., Burroughs R., Golden M. S., Lang H. T. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980 Oct 16;303(16):897–902. doi: 10.1056/NEJM198010163031601. [DOI] [PubMed] [Google Scholar]
  7. Erhardt L. R., Unge G., Boman G. Formation of coronary arterial thrombi in relation to onset of necrosis in acute myocardial infarction in man. A clinical and autoradiographic study. Am Heart J. 1976 May;91(5):592–598. doi: 10.1016/s0002-8703(76)80144-5. [DOI] [PubMed] [Google Scholar]
  8. FLETCHER A. P., SHERRY S., ALKJAERSIG N., SMYRNIOTIS F. E., JICK S. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest. 1959 Jul;38(7):1111–1119. doi: 10.1172/JCI103887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fioretti P., Simoons M. L., Serruys P. W., van den Brand M., Fels P. W., Hugenholtz P. G. Clinical course after attempted thrombolysis in myocardial infarction. Results of pilot studies and preliminary data from a randomized trial. Eur Heart J. 1982 Oct;3(5):422–432. doi: 10.1093/oxfordjournals.eurheartj.a061328. [DOI] [PubMed] [Google Scholar]
  10. Ganz W., Geft I., Shah P. K., Lew A. S., Rodriguez L., Weiss T., Maddahi J., Berman D. S., Charuzi Y., Swan H. J. Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol. 1984 May 1;53(9):1209–1216. doi: 10.1016/0002-9149(84)90066-3. [DOI] [PubMed] [Google Scholar]
  11. Gurewich V., Pannell R., Louie S., Kelley P., Suddith R. L., Greenlee R. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. J Clin Invest. 1984 Jun;73(6):1731–1739. doi: 10.1172/JCI111381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hampton J. R., Gorlin R. Platelet studies in patients with coronary artery disease and in their relatives. Br Heart J. 1972 May;34(5):465–471. doi: 10.1136/hrt.34.5.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kennedy J. W., Ritchie J. L., Davis K. B., Fritz J. K. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 1983 Dec 15;309(24):1477–1482. doi: 10.1056/NEJM198312153092402. [DOI] [PubMed] [Google Scholar]
  14. Kennedy J. W., Ritchie J. L., Davis K. B., Stadius M. L., Maynard C., Fritz J. K. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. N Engl J Med. 1985 Apr 25;312(17):1073–1078. doi: 10.1056/NEJM198504253121701. [DOI] [PubMed] [Google Scholar]
  15. Khaja F., Walton J. A., Jr, Brymer J. F., Lo E., Osterberger L., O'Neill W. W., Colfer H. T., Weiss R., Lee T., Kurian T. Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med. 1983 Jun 2;308(22):1305–1311. doi: 10.1056/NEJM198306023082201. [DOI] [PubMed] [Google Scholar]
  16. Norris R. M., Brandt P. W., Caughey D. E., Lee A. J., Scott P. J. A new coronary prognostic index. Lancet. 1969 Feb 8;1(7589):274–278. doi: 10.1016/s0140-6736(69)91035-6. [DOI] [PubMed] [Google Scholar]
  17. O'Doherty M., Tayler D. I., Quinn E., Vincent R., Chamberlain D. A. Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J (Clin Res Ed) 1983 Apr 30;286(6375):1405–1408. doi: 10.1136/bmj.286.6375.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reimer K. A., Lowe J. E., Rasmussen M. M., Jennings R. B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. doi: 10.1161/01.cir.56.5.786. [DOI] [PubMed] [Google Scholar]
  19. Rentrop K. P., Blanke H., Karsch K. R., Wiegand V., Köstering H., Oster H., Leitz K. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol. 1979 Oct;2(5):354–363. doi: 10.1002/clc.4960020507. [DOI] [PubMed] [Google Scholar]
  20. Schmutzler R., Heckner F., Körtge P., van de Loo J., Poliwoda H., Pezold F. A., Praetorius F., Zekorn D. Zur thrombolytischen Therapie des frischen Herzinfarktes. I. Einführung, Behandlungspläne, allgemeine klinische Ergebnisse. Dtsch Med Wochenschr. 1966 Apr 1;91(13):581–587. doi: 10.1055/s-0028-1110619. [DOI] [PubMed] [Google Scholar]
  21. Schröder R., Vöhringer H., Linderer T., Biamino G., Brüggemann T., Leitner E. V. Follow-up after coronary arterial reperfusion with intravenous streptokinase in relation to residual myocardial infarct artery narrowings. Am J Cardiol. 1985 Feb 1;55(4):313–317. doi: 10.1016/0002-9149(85)90367-4. [DOI] [PubMed] [Google Scholar]
  22. Silver M. D., Baroldi G., Mariani F. The relationship between acute occlusive coronary thrombi and myocardial infarction studied in 100 consecutive patients. Circulation. 1980 Feb;61(2):219–227. doi: 10.1161/01.cir.61.2.219. [DOI] [PubMed] [Google Scholar]
  23. Simoons M. L., Serruys P. W., vd Brand M., Bär F., de Zwaan C., Res J., Verheugt F. W., Krauss X. H., Remme W. J., Vermeer F. Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet. 1985 Sep 14;2(8455):578–582. doi: 10.1016/s0140-6736(85)90584-7. [DOI] [PubMed] [Google Scholar]
  24. Smith R. A., Dupe R. J., English P. D., Green J. Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature. 1981 Apr 9;290(5806):505–508. doi: 10.1038/290505a0. [DOI] [PubMed] [Google Scholar]
  25. Tiefenbrunn A. J., Sobel B. E. Tissue-type plasminogen activator (t-PA): an agent with promise for selective thrombolysis. Int J Cardiol. 1985 Jan;7(1):82–86. doi: 10.1016/0167-5273(85)90181-0. [DOI] [PubMed] [Google Scholar]
  26. Verstraete M., Bernard R., Bory M., Brower R. W., Collen D., de Bono D. P., Erbel R., Huhmann W., Lennane R. J., Lubsen J. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985 Apr 13;1(8433):842–847. doi: 10.1016/s0140-6736(85)92208-1. [DOI] [PubMed] [Google Scholar]
  27. Vincent R., Martin B., Williams G., Quinn E., Robertson G., Chamberlain D. A. A community training scheme in cardiopulmonary resuscitation. Br Med J (Clin Res Ed) 1984 Feb 25;288(6417):617–620. doi: 10.1136/bmj.288.6417.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yusuf S., Ramsdale D., Peto R., Furse L., Bennett D., Bray C., Sleight P. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial. Lancet. 1980 Aug 9;2(8189):273–276. doi: 10.1016/s0140-6736(80)90231-7. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES